Waters Corporation (WAT) on Wednesday said the BD BACTEC FXI Culture System has received U.S. Food and Drug Administration 510(k) clearance.
The BD BACTEC FXI Culture System is a next-generation, fully automated blood culture system designed to improve the speed, consistency, and accuracy of bloodstream infection diagnostics.
The company said the system automates vial loading, unloading, incubation, and detection alerts, and can load up to 60 vials at a time, 50% more than the leading competing system. Clinical study data showed that the BD BACTEC FXI Culture System reduced the mean time to detection by about three hours compared with the previous-generation BD BACTEC FX Blood Culture System.
Waters Corp. shares closed at $371.93 on Tuesday, down 1.65%
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.